2022
DOI: 10.3390/diagnostics12112724
|View full text |Cite
|
Sign up to set email alerts
|

Role of an Automated Deep Learning Algorithm for Reliable Screening of Abnormality in Chest Radiographs: A Prospective Multicenter Quality Improvement Study

Abstract: In medical practice, chest X-rays are the most ubiquitous diagnostic imaging tests. However, the current workload in extensive health care facilities and lack of well-trained radiologists is a significant challenge in the patient care pathway. Therefore, an accurate, reliable, and fast computer-aided diagnosis (CAD) system capable of detecting abnormalities in chest X-rays is crucial in improving the radiological workflow. In this prospective multicenter quality-improvement study, we have evaluated whether art… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 10 publications
(10 citation statements)
references
References 35 publications
0
3
0
Order By: Relevance
“…Predominantly, the AI products reviewed had evidence for their performance provided by the vendor for conformity certification, with 7 having independent, peer reviewed publications available (total publications = 18), with the greatest number originating from Gleamer ( n = 8). The majority of the evidence levels for AI product performance were at Level 3 (ie, change in diagnosis with and without AI assistance) and with some products (eg, BoneView Gleamer , 36 , 38 , 39 Annalise Enterprise CXR v1.2 Annalise.AI , 46 Qure.AI qXR 48 ) potentially demonstrating evidence at Level 4 (ie, demonstrating improvement in time for diagnosis, which could be argued may lead to swifter treatment or follow-up for the patient 38 ). There was no evidence available to demonstrate a benefit in actual patient outcome (eg, reduced time for recovery, reduction in repeated hospital visits, etc.…”
Section: Evidence Levelsmentioning
confidence: 99%
“…Predominantly, the AI products reviewed had evidence for their performance provided by the vendor for conformity certification, with 7 having independent, peer reviewed publications available (total publications = 18), with the greatest number originating from Gleamer ( n = 8). The majority of the evidence levels for AI product performance were at Level 3 (ie, change in diagnosis with and without AI assistance) and with some products (eg, BoneView Gleamer , 36 , 38 , 39 Annalise Enterprise CXR v1.2 Annalise.AI , 46 Qure.AI qXR 48 ) potentially demonstrating evidence at Level 4 (ie, demonstrating improvement in time for diagnosis, which could be argued may lead to swifter treatment or follow-up for the patient 38 ). There was no evidence available to demonstrate a benefit in actual patient outcome (eg, reduced time for recovery, reduction in repeated hospital visits, etc.…”
Section: Evidence Levelsmentioning
confidence: 99%
“…Table 1 shows different clinical studies of the effectiveness of Qure.AI, considered as the main evidence base for this review, as these studies demonstrate the use of AI in the health field and its respective results [9][10][11][12][13][14]. As demonstrated in Table 1, numerous international studies highlight the effectiveness of using Qure.AI's qXR in the healthcare field.…”
Section: Resultsmentioning
confidence: 99%
“…A model for automatic diagnosis of different diseases based on chest radiographs using machine learning algorithms has been proposed [ 11 ]. In a multicenter study, AI was used as a chest X-ray screening tool and achieved good performance in detecting normal and abnormal chest X-rays, reducing turnaround time, and assisting radiologists in assessing pathology [ 12 ]. AI solutions for chest X-ray evaluation have been demonstrated to be practical, perform well, and provide benefits in clinical settings [ 13 ].…”
Section: Discussionmentioning
confidence: 99%